SurModics, Inc. provides drug delivery and surface modification technologies to the healthcare industry. The company offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, urology, and other markets. It also provides in vitro diagnostic component products and technologies comprising protein stabilization reagents, substrates, polymers and reagent chemicals, antigens, and surface coatings for diagnostic test kits and biomedical research applications. SurModics, Inc. markets its technologies and products worldwide through direct sales force consisting of sales professionals. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.